​

Affimed (AFMD) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

AFMD Stock Forecast

Affimed (AFMD) stock forecast, based on 13 Wall Street analysts, predicts a 12-month average price target of $7.50, with a high of $10.00 and a low of $5.00. This represents a 927.40% increase from the last price of $0.73.

- $2 $4 $6 $8 $10 High: $10 Avg: $7.5 Low: $5 Last Closed Price: $0.73

AFMD Stock Rating

Affimed stock's rating consensus is Buy, based on 13 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 11 Buy (84.62%), 2 Hold (15.38%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 13 0 2 11 Strong Sell Sell Hold Buy Strong Buy

AFMD Price Target Upside V Benchmarks

TypeNameUpside
StockAffimed927.40%
SectorHealthcare Stocks 33.91%
IndustryBiotech Stocks 83.49%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.73$0.73$0.73
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2524---6
Mar, 2524---6
Feb, 2524---6
Jan, 25251--8
Dec, 24251--8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 01, 2024Bradley CaninoStifel Nicolaus$5.00$5.30-5.66%584.93%
Apr 01, 2024Swayampakula RamakanthH.C. Wainwright$10.00$5.3088.68%1269.86%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 18, 2024Wells FargoOverweightOverweighthold
Nov 15, 2024H.C. WainwrightBuyBuyhold
Jun 12, 2024LaidlawBuyBuyhold
Apr 01, 2024H.C. WainwrightBuyBuyhold
Dec 12, 2022H.C. WainwrightBuyinitialise
Oct 11, 2022Stifel NicolausPositivedowngrade
Mar 31, 2022Piper SandlerOverweightinitialise
Feb 23, 2022Cantor FitzgeraldOverweightinitialise

Financial Forecast

EPS Forecast

$-15 $-11 $-7 $-3 $1 $5 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.50$-0.48$-0.60------
Avg Forecast$-3.17$-4.66$-5.69$-7.37$-4.06$-2.33$-2.29$-1.89$-1.67
High Forecast$0.09$0.13$-0.85$-6.91$-3.93$-1.20$0.14$0.11$0.10
Low Forecast$-7.99$-11.75$-10.46$-7.82$-4.14$-3.44$-8.38$-6.93$-6.11
Surprise %-84.23%-89.70%-89.46%------

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$28.36M$40.37M$41.35M$8.28M-----
Avg Forecast$39.35M$43.92M$39.91M$10.53M$1.79M$5.86M$20.26M$18.58M$48.75M
High Forecast$85.45M$95.39M$65.65M$12.23M$2.12M$9.69M$61.74M$56.61M$148.58M
Low Forecast$8.25M$9.21M$13.80M$7.44M$1.45M$2.04M$3.74M$3.43M$9.01M
Surprise %-27.93%-8.10%3.61%-21.42%-----

Net Income Forecast

$-200M $-150M $-100M $-50M $0 $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-41.37M$-57.52M$-86.00M$-105.94M-----
Avg Forecast$-47.30M$-69.57M$-84.98M$-110.16M$-60.59M$-34.87M$-34.17M$-28.27M$-24.94M
High Forecast$1.29M$1.90M$-12.71M$-103.23M$-58.71M$-17.86M$2.04M$1.69M$1.49M
Low Forecast$-119.33M$-175.53M$-156.23M$-116.81M$-61.89M$-51.37M$-125.14M$-103.51M$-91.33M
Surprise %-12.54%-17.31%1.20%-3.84%-----

AFMD Forecast FAQ

Is Affimed stock a buy?

Affimed stock has a consensus rating of Buy, based on 13 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 11 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Affimed is a favorable investment for most analysts.

What is Affimed's price target?

Affimed's price target, set by 13 Wall Street analysts, averages $7.5 over the next 12 months. The price target range spans from $5 at the low end to $10 at the high end, suggesting a potential 927.40% change from the previous closing price of $0.73.

How does Affimed stock forecast compare to its benchmarks?

Affimed's stock forecast shows a 927.40% upside, outperforming the average forecast for the healthcare stocks sector (33.91%) and outperforming the biotech stocks industry (83.49%).

What is the breakdown of analyst ratings for Affimed over the past three months?

  • April 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Affimed’s EPS forecast?

Affimed's average annual EPS forecast for its fiscal year ending in December 2024 is $-4.06, marking a 0% decrease from the reported $0 in 2023. Estimates for the following years are $-2.33 in 2025, $-2.29 in 2026, $-1.89 in 2027, and $-1.67 in 2028.

What is Affimed’s revenue forecast?

Affimed's average annual revenue forecast for its fiscal year ending in December 2024 is $1.79M, reflecting a -78.38% decrease from the reported $8.28M in 2023. The forecast for 2025 is $5.86M, followed by $20.26M for 2026, $18.58M for 2027, and $48.75M for 2028.

What is Affimed’s net income forecast?

Affimed's net income forecast for the fiscal year ending in December 2024 stands at $-60.59M, representing a -42.81% decrease from the reported $-106M in 2023. Projections indicate $-34.869M in 2025, $-34.173M in 2026, $-28.268M in 2027, and $-24.942M in 2028.